Shanghai RAAS Blood Products Co., Ltd. (SHE: 002252)
China
· Delayed Price · Currency is CNY
7.22
0.00 (0.00%)
Dec 20, 2024, 3:04 PM CST
Shanghai RAAS Blood Products Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,830 | 1,779 | 1,880 | 1,295 | 1,324 | 607.89 | Upgrade
|
Depreciation & Amortization | 158.99 | 158.99 | 184.98 | 159.27 | 152.76 | 148.46 | Upgrade
|
Other Amortization | 13.52 | 13.52 | 9.94 | 9.55 | 11.25 | 8.75 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.23 | 1.35 | -0.97 | -3.31 | Upgrade
|
Asset Writedown & Restructuring Costs | 4.31 | 4.31 | 199.5 | 370.45 | 132.51 | 143.31 | Upgrade
|
Loss (Gain) From Sale of Investments | 196.89 | 196.89 | -430.77 | 42.76 | -537.65 | 13.73 | Upgrade
|
Stock-Based Compensation | 21.61 | 21.61 | - | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | -5.22 | -5.22 | 16.38 | -10.83 | 3.95 | -0.99 | Upgrade
|
Other Operating Activities | -1,564 | -89.3 | -94.55 | -435.77 | -9.38 | 64.93 | Upgrade
|
Change in Accounts Receivable | 163.23 | 163.23 | -286.97 | -75.16 | 253.86 | 90 | Upgrade
|
Change in Inventory | -417.74 | -417.74 | -106.32 | -1,014 | -259.26 | -240.86 | Upgrade
|
Change in Accounts Payable | 449.23 | 449.23 | 333.94 | 961.09 | 24.96 | 7.33 | Upgrade
|
Operating Cash Flow | 853.06 | 2,278 | 1,726 | 1,294 | 1,169 | 872.69 | Upgrade
|
Operating Cash Flow Growth | -65.36% | 32.01% | 33.35% | 10.71% | 33.94% | 232.45% | Upgrade
|
Capital Expenditures | -407.85 | -450.8 | -225.73 | -204.61 | -251.76 | -154.88 | Upgrade
|
Sale of Property, Plant & Equipment | 2.96 | 2.33 | 2.24 | 3.19 | 9.03 | 7.32 | Upgrade
|
Cash Acquisitions | -440.69 | -440.69 | - | - | - | -0.29 | Upgrade
|
Investment in Securities | -1,035 | 141.72 | -946.68 | -609.51 | -373.01 | -16.59 | Upgrade
|
Other Investing Activities | 93.3 | 76.84 | 39.97 | 80.11 | 7.02 | 12.1 | Upgrade
|
Investing Cash Flow | -1,787 | -670.59 | -1,130 | -730.82 | -608.73 | -152.33 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 7.74 | - | Upgrade
|
Total Debt Issued | - | - | - | - | 7.74 | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | -7.74 | - | -150 | Upgrade
|
Long-Term Debt Repaid | - | -2.04 | -5.73 | -4.21 | - | - | Upgrade
|
Total Debt Repaid | -4.68 | -2.04 | -5.73 | -11.95 | - | -150 | Upgrade
|
Net Debt Issued (Repaid) | -4.68 | -2.04 | -5.73 | -11.95 | 7.74 | -150 | Upgrade
|
Issuance of Common Stock | 113.17 | 113.17 | - | - | - | - | Upgrade
|
Repurchase of Common Stock | -1,000 | -1,000 | - | - | - | - | Upgrade
|
Common Dividends Paid | -423.68 | -202.22 | -188.74 | -168.52 | -67.78 | -1.6 | Upgrade
|
Other Financing Activities | 815.86 | -43.13 | 1.09 | 1.19 | 1.19 | 1.16 | Upgrade
|
Financing Cash Flow | -499.31 | -1,134 | -193.38 | -179.28 | -58.84 | -150.44 | Upgrade
|
Foreign Exchange Rate Adjustments | -5.42 | -3.31 | 11.75 | -2.26 | -4.76 | 0.65 | Upgrade
|
Net Cash Flow | -1,439 | 469.77 | 413.78 | 381.66 | 496.51 | 570.58 | Upgrade
|
Free Cash Flow | 445.21 | 1,827 | 1,500 | 1,089 | 917.09 | 717.82 | Upgrade
|
Free Cash Flow Growth | -77.91% | 21.82% | 37.68% | 18.79% | 27.76% | 580.00% | Upgrade
|
Free Cash Flow Margin | 5.34% | 22.94% | 22.84% | 25.41% | 33.21% | 27.77% | Upgrade
|
Free Cash Flow Per Share | 0.07 | 0.27 | 0.22 | 0.16 | 0.14 | 0.14 | Upgrade
|
Cash Interest Paid | - | - | - | 0.03 | - | - | Upgrade
|
Cash Income Tax Paid | 494.14 | 644.74 | 593.92 | 339.12 | 220.76 | 204.68 | Upgrade
|
Levered Free Cash Flow | 103.73 | 1,594 | 1,180 | 748.69 | 564.79 | 518.35 | Upgrade
|
Unlevered Free Cash Flow | 103.79 | 1,594 | 1,180 | 748.99 | 565.03 | 519.4 | Upgrade
|
Change in Net Working Capital | 1,092 | -402.78 | 31.87 | 129.03 | -15.51 | 42.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.